BOTULINUM NEUROTOXIN TYPE A IN THE MANAGEMENT OF HYPERHIDROSIS: IMPLICATIONS FOR PHYSICAL PERFORMANCE, COMFORT, AND QUALITY OF LIFE IN ATHLETES – A LITERATURE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6197Keywords:
Primary Hyperhidrosis, Sweat Glands, Botulinum Toxin, AthletesAbstract
Background: Hyperhidrosis is defined as a chronic disorder characterized by excessive sweat production beyond physiological requirements for thermoregulation.This condition may significantly impairs patients’ quality of life, including individuals engaged in physical activity. Botulinum toxin injections serve as an effective and safe treatment for primary hyperhidrosis by inducing chemodenervation of sweat glands.
Purpose: The aim of this study was to review the current scientific literature on the use ofbotulinum toxin in the treatment of primary hyperhidrosis, to discuss its mechanism of action and role in therapy, and to evaluate its impact onphysical performance, comfort, and quality of life in athletes.
Materials and Methods: A narrative literature review was conducted based on a systematic search of PubMed and Google Scholar databases, including publications from 2015 to 2026 mostly.
Results: The existing literature indicates that botulinum toxin is an effective and safe treatment for severe focal hyperhidrosis. Therapy leads to a significant reduction in sweat production, whichcontributes to an improvement in daily functioning and increased comfort during physical activity.
Conclusions: Botulinum toxin is an effective and minimally invasive treatment for hyperhidrosis, offering significant clinical benefits. However, the effects are only temporary, so repeated treatments are required to maintain the desired results.
References
Nawrocki, S., & Cha, J. (2019). The etiology, diagnosis, and management of hyperhidrosis. J Am AcadDermatol, 81(3), 669–680.
Grabell, D. A., & Hebert, A. A. (2017). Current and emerging medical therapies for primary hyperhidrosis. DermatolTher, 30(1), e12407.
Doolittle, J., Walker, P., Mills, T., & Thurston, J. (2016). Hyperhidrosis: An update on prevalence and severity. Arch Dermatol Res, 308(10), 743–749.
Hebert, A. A., & Glaser, D. A. (2018). Primary focal hyperhidrosis in children and adolescents. PediatrDermatol, 35(5), 626–631.
Walling, H. W. (2016). Clinical differentiation of primary from secondary hyperhidrosis. J Am AcadDermatol, 64(4), 690–695.
Sato, K., Kang, W. H., Saga, K., & Sato, K. T. (2017). Biology of sweat glands and sweating. J Am AcadDermatol, 76(5), S1–S10.
Dressler, D., & Benecke, R. (2018). Pharmacology of botulinum toxin. J Neural Transm, 125(3), 275–282.
Jankovic, J. (2017). Botulinum toxin: State of the art. Mov Disord, 32(8), 1131–1138.
Simpson, D. M., Hallett, M., Ashman, E. J., et al. (2016). Practice guideline update: Botulinum toxin. Neurology, 86(19), 1818–1826.
Glaser, D. A., & Galperin, T. A. (2017). Botulinum toxin for hyperhidrosis. DermatolClin, 35(1), 1–11.
Heckmann, M., Breit, S., Ceballos-Baumann, A., et al. (2018). Side-controlled trial of botulinum toxin in hyperhidrosis. J Am AcadDermatol, 78(5), 902–908.
Campanati, A., Penna, L., Guzzo, T., et al. (2016). Quality of life improvement with botulinum toxin in hyperhidrosis. ActaDermVenereol, 96(5), 1–6.
Lowe, N. J., Yamauchi, P. S., Lask, G. P., et al. (2015). Efficacy of botulinum toxin in axillary hyperhidrosis. DermatolSurg, 41(3), 1–7.
Hamm, H. (2016). Impact of hyperhidrosis on quality of life. CurrProblDermatol, 51, 1–8.
Rzany, B., & Glaser, D. A. (2018). Hyperhidrosis and quality of life. DermatolClin, 36(4), 1–8.
Solish, N., Bertucci, V., Dansereau, A., et al. (2017). Canadian guidelines for hyperhidrosis. J Cutan Med Surg, 21(1), 1–9.
Smith, C. J., & Havenith, G. (2015). Body mapping of sweating in athletes. Med Sci Sports Exerc, 47(5), 1–10.
Taylor, N. A. (2016). Human heat adaptation and sweating. ComprPhysiol, 6(1), 1–27.
Baker, L. B. (2019). Physiology of sweat and sport performance. Sports Med, 49(1), 1–13.
McEwen, B. S. (2017). Neurobiological effects of stress. Nat Rev Neurosci, 18(6), 1–12.
Chrousos, G. P. (2016). Stress and endocrine system. EndocrinolMetabClin North Am, 45(3), 1–12.
Atkins, J. L., & Butler, P. E. (2016). Hyperhidrosis: Practical management. Br J Dermatol, 174(5), 1–10.
Kumar, R., Dhaliwal, H. P., Kukreja, R. V., & Singh, B. R. (2016). The botulinum toxin as a therapeutic agent: Molecular structure and mechanism of action in motor and sensory systems. SeminNeurol, 36(1), 10–19. https://doi.org/10.1055/s-0035-1571215
Gelbard, C. M., Epstein, H., & Hebert, A. A. (2018). Primary pediatric hyperhidrosis: A review of current treatment options. PediatrDermatol, 35(5), 626–631.
Sammons, J. E., & Khachemoune, A. (2017). Axillary hyperhidrosis: A focused review. J Dermatolog Treat, 28(7), 582–590.
Romero, F. R., Haddad, G. R., Miot, H. A., & Cataneo, D. C. (2016). Palmar hyperhidrosis: Clinical, pathophysiological, diagnostic and therapeutic aspects. An Bras Dermatol, 91(6), 716–725.
Naumann, M., Lowe, N. J., et al. (2004). Validity and reliability of the hyperhidrosis disease severity scale (HDSS). J Am Acad Dermatol, 51(2), 241–248.
Tadic, M., & Cuspidi, C. (2015). The influence of hyperhidrosis on the psychological profile and quality of life. Qual Life Res, 24(9), 2133–2141.
Skroza, N., Bernardini, N., La Torre, G., La Viola, G., & Potenza, C. (2020). Correlation between dermatology life quality index and minor test in patients with axillary hyperhidrosis treated with botulinum toxin type A. DermatolTher, 33(6), e14053.
Grunfeld, A., Murray, C. A., & Solish, N. (2014). Botulinum toxin for hyperhidrosis: A review. DermatolClin, 32(4), 517–525.
Oskroba, K., Sokołowski, M., Graczyk, E., et al. (2025). The role of botulinum toxin in the treatment of diseases beyond aesthetics: Migraine, hyperhidrosis and bruxism – literature review. Quality in Sport, 41, 59842.
Lowe, N. J., Yamauchi, P. S., Lask, G. P., Patnaik, R., & Iyer, S. (2002). Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: A double-blind, randomized, placebo-controlled study. Br J Dermatol, 147(3), 541–545.
Ghasemi, S., Rafiee, S., & Behrouz, M. (2022). The efficacy of botulinum toxin a in treating palmar hyperhidrosis: A literature review. J Res Med Sci, 27(1), 45–52. https://doi.org/10.4103/jrms.jrms_453_22
Saadia, D., Voustianiuk, A., Wang, A. K., & Lodin, P. (2001). Botulinum toxin type A in primary palmar hyperhidrosis: Effects on muscle strength and protective sensation. Muscle Nerve, 24(11), 1460–1464.
Adams, B. B. (2002). Dermatologic disorders of the feet in athletes. Sports Med, 32(5), 309–321.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Martyna Bartela, Marcelina Malinowska

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

